node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ENSPREP00000030771 | LOC103476518 | ENSPREP00000030771 | ENSPREP00000010687 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2a. | 0.533 |
ENSPREP00000030771 | LOC103480255 | ENSPREP00000030771 | ENSPREP00000009026 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 4a. | 0.533 |
ENSPREP00000030771 | igf1 | ENSPREP00000030771 | ENSPREP00000010429 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1. | 0.471 |
ENSPREP00000030771 | igf2 | ENSPREP00000030771 | ENSPREP00000029568 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | IlGF domain-containing protein. | 0.416 |
ENSPREP00000030771 | insr | ENSPREP00000030771 | ENSPREP00000020007 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor a. | 0.766 |
ENSPREP00000030771 | irs2 | ENSPREP00000030771 | ENSPREP00000033662 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2b. | 0.533 |
LOC103467754 | LOC103476518 | ENSPREP00000001691 | ENSPREP00000010687 | Tyrosine-protein phosphatase non-receptor type. | Insulin receptor substrate 2a. | 0.916 |
LOC103467754 | LOC103480255 | ENSPREP00000001691 | ENSPREP00000009026 | Tyrosine-protein phosphatase non-receptor type. | Insulin receptor substrate 4a. | 0.916 |
LOC103467754 | insr | ENSPREP00000001691 | ENSPREP00000020007 | Tyrosine-protein phosphatase non-receptor type. | Insulin receptor a. | 0.705 |
LOC103467754 | irs2 | ENSPREP00000001691 | ENSPREP00000033662 | Tyrosine-protein phosphatase non-receptor type. | Insulin receptor substrate 2b. | 0.916 |
LOC103472442 | insr | ENSPREP00000012910 | ENSPREP00000020007 | Tyrosine-protein phosphatase non-receptor type. | Insulin receptor a. | 0.705 |
LOC103476384 | LOC103476518 | ENSPREP00000025882 | ENSPREP00000010687 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2a. | 0.533 |
LOC103476384 | LOC103480255 | ENSPREP00000025882 | ENSPREP00000009026 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 4a. | 0.533 |
LOC103476384 | igf1 | ENSPREP00000025882 | ENSPREP00000010429 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1. | 0.471 |
LOC103476384 | igf2 | ENSPREP00000025882 | ENSPREP00000029568 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | IlGF domain-containing protein. | 0.416 |
LOC103476384 | insr | ENSPREP00000025882 | ENSPREP00000020007 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor a. | 0.766 |
LOC103476384 | irs2 | ENSPREP00000025882 | ENSPREP00000033662 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2b. | 0.533 |
LOC103476518 | ENSPREP00000030771 | ENSPREP00000010687 | ENSPREP00000030771 | Insulin receptor substrate 2a. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.533 |
LOC103476518 | LOC103467754 | ENSPREP00000010687 | ENSPREP00000001691 | Insulin receptor substrate 2a. | Tyrosine-protein phosphatase non-receptor type. | 0.916 |
LOC103476518 | LOC103476384 | ENSPREP00000010687 | ENSPREP00000025882 | Insulin receptor substrate 2a. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.533 |